Avantor Results Presentation Deck

Summary hmi Strong business momentum Strong revenue, margin expansion and earnings growth Pervasive growth across enterprise Execution of profitability drivers (volume, commercial excellence and mix) - Executing on our long-term growth strategy Continued focus on proprietary growth through Biopharma platform Investing in core capabilities to sustain long-term growth M&A contributing; Masterflex close imminent - Looking ahead Stable core growth offset by COVID headwinds Raising organic revenue growth, Adjusted EBITDA margin and adjusted EPS guidance for FY21 Focused on M&A integration and deleveraging - - - avantor™ 5 10

View entire presentation